ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
AMSilk, a German start-up making synthetic silk protein via bacterial fermentation, has raised $35 million in a series C investment round led by Novo Holdings, a major shareholder in Novo Nordisk and Novozymes. Other investors include Cargill. AMSilk’s protein is used in applications such as fibers to make sportswear. The firm will use the money to expand its manufacturing base and increase international sales. This is Novo Holdings’ 12th investment in a bioindustrial company.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X